Acadia Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Summary

Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) will participate in several upcoming virtual investor conferences, including the Citi’s 16th Annual BioPharma Virtual Conference on September 10, 2021, Morgan Stanley Virtual 19th Annual Global Healthcare Conference on September 13, 2021, and the 2021 Cantor Virtual Global Healthcare Conference on September 27, 2021. Live webcasts will be accessible on the company’s website under the investors section, with archived recordings available for a month post-event.

SAN DIEGO--(BUSINESS WIRE)-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at the following upcoming investor conferences:

Citi’s 16^th Annual BioPharma Virtual Conference
Fireside Chat Presentation: Friday, September 10, 2021 at 11:35 a.m. Eastern Time

Morgan Stanley Virtual 19^th Annual Global Healthcare Conference
Fireside Chat Presentation: Monday, September 13, 2021 at 11:45 a.m. Eastern Time

2021 Cantor Virtual Global Healthcare Conference
Fireside Chat Presentation: Monday, September 27, 2021 at 1:20 p.m. Eastern Time

These conferences will be held virtually. Live webcasts of the presentations will be accessible on the company’s website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website for approximately one month following each presentation.

About Acadia Pharmaceuticals

Acadia is trailblazing breakthroughs in neuroscience to elevate life. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinson’s disease psychosis. Our late-stage development efforts are focused on dementia-related psychosis, negative symptoms of schizophrenia and Rett syndrome, and in early-stage clinical research we are exploring novel approaches to pain management, and cognition and neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at www.acadia-pharm.com and follow us on LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210902005241/en/

Media Contact:

Acadia Pharmaceuticals Inc.

Eric Endicott

(858) 914-7161

media@acadia-pharm.com

Investor Contact:

Acadia Pharmaceuticals Inc.

Mark Johnson, CFA

(858) 261-2771

ir@acadia-pharm.com

Source: Acadia Pharmaceuticals Inc.

FAQ

What investor conferences is Acadia Pharmaceuticals participating in September 2021?

Acadia Pharmaceuticals will participate in Citi’s BioPharma Conference on September 10, Morgan Stanley's Healthcare Conference on September 13, and Cantor's Healthcare Conference on September 27, 2021.

When is Acadia Pharmaceuticals' presentation at the Citi Conference?

Acadia Pharmaceuticals' presentation at the Citi’s 16th Annual BioPharma Virtual Conference is scheduled for September 10, 2021, at 11:35 a.m. Eastern Time.

How can I access Acadia Pharmaceuticals' conference presentations?

The presentations can be accessed via live webcasts on Acadia Pharmaceuticals' website in the investors section, with recordings archived for about a month afterwards.

What time is Acadia Pharmaceuticals' presentation at the Morgan Stanley Conference?

The presentation at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference is set for September 13, 2021, at 11:45 a.m. Eastern Time.

What is the schedule for Acadia Pharmaceuticals’ presentations in September 2021?

Acadia Pharmaceuticals is scheduled for presentations on September 10, 13, and 27 in 2021, at various times throughout the day.